Discover the detailed record of transactions filed by 최희경, Chief Executive Officer. Insider active across 2 companies, notably 지투지바이오. Aggregated, 11 disclosures have been logged. Activity tracked since 25 March 2026. The latest transaction was disclosed on 25 March 2026 (Purchase). Regulator: DART (FSS). All data is accessible without signup.
Choi Hee-kyung is the Executive Director at G2G Bio, a company specializing in biotechnology. In this role, she oversees the company's operations and strategy. G2G Bio is recognized for its innovations in the biotechnology field.